Norlase

Norlase is an ophthalmic laser manufacturer that develops portable green laser therapy systems for retina and glaucoma treatment( The company's product portfolio includes four devices: LYNX( the first laser indirect ophthalmoscope with integrated pattern scanning capability requiring no external laser console( fiber tether( or wall power; ECHO( combining an ultra-compact laser engine with MEMS pattern technology in an integrated design eliminating bulky tables and cables; LION( a battery-powered indirect ophthalmoscope integrated with a green laser source featuring a wireless user interface( voice control of parameters( and no fiber tether for ultimate portability; and LEAF( a first-of-its-kind green laser photocoagulator with an ultra-compact design that attaches directly to existing slit lamps without external fibers or cart space( Norlase reported over 40% global install base growth in 2025 and secured 20 million euros in EIB venture debt( The company serves ophthalmologists with laser photocoagulation( laser treatment for macular degeneration( laser treatment for glaucoma( and retinal hole treatment applications( Founded in 2014 and headquartered in Ballerup( Denmark( the company has raised $11.0M in Series B funding from investors including EIC Fund( West Hill Capital( Europa( and European.